EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Stratified Randomized Controlled Trial of ∅3.3 mm Versus ∅4.1 mm Hydrophilic Titanium‐Zirconium Implants Supporting Posterior Mandibular Fixed Prostheses in Hyperglycaemic Subjects

Supriya Ebenezer iD, Sreelakshmi Viswanath iD, Chitradevi Ramanathan iD, Alampalli V Ramesh, Vinay V Kumar iD

Clinical Oral Implants Research · 2026-11 · 37 (11) · 1328-1349

DOI: 10.1111/clr.70175 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, online erschienen am 24.09.2026. Verfasst von Supriya Ebenezer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oral Rehabilitation Center, Bangalore, India. Hauptthemen laut MEDLINE: Zirconium, Dental Prosthesis, Implant-Supported, Dental Implants, Hyperglycemia. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Team for Implantology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare ⌀3.3 mm and ⌀4.1 mm hydrophilic titanium‐zirconium implants supporting fixed dental prostheses (FDPs) in mandibular distal‐extension situations among participants with varying degrees of hyperglycaemia. Materials and Methods Participants were stratified according to HbA1c (5.8%–< 7.0% vs. ≥ 7.0%) and subsequently randomized within each stratum to receive either ⌀3.3 mm or ⌀4.1 mm titanium‐zirconium implants. Each participant received a two‐implant‐supported multi‐unit FDP. The primary outcome was marginal bone level (MBL) change at 12 months after prosthesis delivery. Secondary outcomes included implant stability quotient (ISQ), peri‐implant indices, Healing Index and patient‐reported outcomes.

Results

Of 88 enrolled participants, 83 (166 implants) were evaluated. Implant survival was 100%, with no peri‐implantitis. At 12 months, MBL did not differ significantly between the ⌀3.3 mm [0.27 mm (IQR, 0.07–0.68)] and ⌀4.1 mm groups [0.27 mm (IQR, −0.04 to 0.54); p = 0.078]. Participants with HbA1c ≥ 7% had approximately sevenfold higher odds of MBL ≥ 0.5 mm than those with HbA1c < 7%. Secondary ISQ was significantly higher with ⌀4.1 mm implants (79.6 vs. 76.1; p < 0.001), whereas early healing was better with ⌀3.3 mm implants ( p = 0.005). Chewing ability improved significantly from baseline to 12 months irrespective of implant diameter or HbA1c category ( p < 0.0001).

Conclusion

At 1 year, ⌀3.3 mm and ⌀4.1 mm hydrophilic Ti‐Zr implants demonstrated no statistically significant difference in MBL although ⌀4.1 mm implants demonstrated higher stability. Patient‐reported chewing ability improved substantially following rehabilitation for both implant diameters. Higher HbA1c was associated with greater odds of clinically relevant MBL. Trial Registration The trial was registered prospectively with the Clinical Trials Registry–India (CTRI/2017/08/009315)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumDental Prosthesis, Implant-SupportedDental ImplantsHyperglycemiaDenture, Partial, FixedHumansTitaniumFemaleMaleMiddle AgedGlycated HemoglobinAgedDental Prosthesis DesignMandibleTreatment OutcomeDental Implantation, Endosseous

Stichwörter der Autor:innen

Type 2 diabetes mellitusalveolar bone lossdental implantsglycated haemoglobinosseointegrationtitaniumzirconium

Substanzen

ZirconiumTitaniumDental ImplantsGlycated Hemoglobin

Autor:innen und Institutionen

  • Oral Rehabilitation Center, Bangalore, India.
  • Sankara Nethralaya Medical Research Foundation, Chennai, India.
  • Dental Health Clinic, Bangalore, India.
  • Department of Odontology Maxillofacial Surgery, Division of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Coorg Institute of Dental Sciences, Karnataka, India.
  • Department of Maxillofacial Surgery and Dentistry, Vydehi Superspeciality Hospital, Bangalore, India.

ORCID-Profile: Supriya Ebenezer, Sreelakshmi Viswanath, Chitradevi Ramanathan, Vinay V Kumar

Förderung

  • International Team for Implantology

Zitieren

APA

Ebenezer, S., Viswanath, S., Ramanathan, C., Ramesh, A. V., & Kumar, V. V. (2026). Stratified Randomized Controlled Trial of ∅3.3 mm Versus ∅4.1 mm Hydrophilic Titanium‐Zirconium Implants Supporting Posterior Mandibular Fixed Prostheses in Hyperglycaemic Subjects. Clinical Oral Implants Research, 37(11), 1328-1349. https://doi.org/10.1111/clr.70175

Vancouver

Ebenezer S, Viswanath S, Ramanathan C, Ramesh AV, Kumar VV. Stratified Randomized Controlled Trial of ∅3.3 mm Versus ∅4.1 mm Hydrophilic Titanium‐Zirconium Implants Supporting Posterior Mandibular Fixed Prostheses in Hyperglycaemic Subjects. Clinical Oral Implants Research. 2026;37(11):1328-1349. doi:10.1111/clr.70175

BibTeX
@article{Ebenezer2026,
  author = {Ebenezer, Supriya and Viswanath, Sreelakshmi and Ramanathan, Chitradevi and Ramesh, Alampalli V and Kumar, Vinay V},
  title = {Stratified Randomized Controlled Trial of ∅3.3 mm Versus ∅4.1 mm Hydrophilic Titanium‐Zirconium Implants Supporting Posterior Mandibular Fixed Prostheses in Hyperglycaemic Subjects},
  journal = {Clinical Oral Implants Research},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {1328--1349},
  doi = {10.1111/clr.70175}
}
Kostenlos starten →